Pzena Investment Management LLC Has $24.86 Million Stake in Ambev S.A. $ABEV

Key Points

• Pzena Investment Management LLC has reduced its stake in Ambev S.A. by 25.5%, owning approximately 10.3 million shares valued at $24.86 million.
• The company has declared a dividend increase, now paying $0.023 per share, with a yield of 660% and a payout ratio of 25%.
• Ambev's recent earnings report showed a net revenue of $3.59 billion and an EPS of $0.03, meeting analysts' expectations.

Pzena Investment Management LLC trimmed its holdings in Ambev S.A. (NYSE:ABEV - Free Report) by 25.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,315,005 shares of the company's stock after selling 3,524,497 shares during the period. Pzena Investment Management LLC owned about 0.07% of Ambev worth $24,859,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Vanguard Personalized Indexing Management LLC grew its stake in Ambev by 23.8% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 113,292 shares of the company's stock valued at $273,000 after acquiring an additional 21,791 shares during the period. Blue Trust Inc. grew its stake in Ambev by 18.5% in the second quarter. Blue Trust Inc. now owns 171,624 shares of the company's stock valued at $414,000 after acquiring an additional 26,793 shares during the period. IFP Advisors Inc grew its stake in Ambev by 7.5% in the second quarter. IFP Advisors Inc now owns 118,102 shares of the company's stock valued at $285,000 after acquiring an additional 8,284 shares during the period. Callan Family Office LLC grew its stake in Ambev by 152.8% in the second quarter. Callan Family Office LLC now owns 216,501 shares of the company's stock valued at $522,000 after acquiring an additional 130,867 shares during the period. Finally, Mraz Amerine & Associates Inc. boosted its position in shares of Ambev by 5.3% during the second quarter. Mraz Amerine & Associates Inc. now owns 724,436 shares of the company's stock worth $1,746,000 after buying an additional 36,765 shares during the period. 8.13% of the stock is owned by institutional investors and hedge funds.

Ambev Stock Performance

Shares of NYSE ABEV opened at $2.12 on Monday. The stock has a 50 day moving average price of $2.23 and a 200 day moving average price of $2.35. Ambev S.A. has a 52 week low of $1.76 and a 52 week high of $2.63. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.80 and a current ratio of 1.11. The stock has a market capitalization of $33.41 billion, a PE ratio of 13.25, a price-to-earnings-growth ratio of 2.12 and a beta of 0.85.

Ambev (NYSE:ABEV - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $0.03 EPS for the quarter, meeting the consensus estimate of $0.03. Ambev had a return on equity of 15.39% and a net margin of 16.18%.The firm had revenue of $3.59 billion during the quarter, compared to analysts' expectations of $21.84 billion. Analysts predict that Ambev S.A. will post 0.18 earnings per share for the current fiscal year.

Ambev Increases Dividend

The business also recently declared a -- dividend, which will be paid on Tuesday, October 14th. Investors of record on Monday, August 11th will be given a dividend of $0.023 per share. This represents a yield of 660.0%. This is a boost from Ambev's previous -- dividend of $0.02. The ex-dividend date of this dividend is Monday, August 11th. Ambev's payout ratio is currently 25.00%.

Analyst Ratings Changes

ABEV has been the subject of several recent research reports. UBS Group reduced their price objective on Ambev from $2.50 to $2.20 and set a "neutral" rating for the company in a research report on Wednesday, August 20th. Hsbc Global Res raised Ambev to a "hold" rating in a research report on Friday, August 1st. Zacks Research raised Ambev from a "strong sell" rating to a "hold" rating in a research report on Tuesday, September 30th. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Ambev in a research report on Wednesday, October 8th. Finally, HSBC reaffirmed a "hold" rating on shares of Ambev in a research report on Friday, August 1st. Eight analysts have rated the stock with a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, Ambev presently has an average rating of "Reduce" and a consensus target price of $2.35.

Ambev Company Profile

Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, malt and food, other alcoholic beverages, and non-alcoholic and non-carbonated products in Brazil, Central America and Caribbean, Latin America South, and Canada. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe, Hoegaarden, Balboa ICE, Balboa, Atlas Golden Light, Atlas, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Bud 66, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.

Want to see what other hedge funds are holding ABEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambev S.A. (NYSE:ABEV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.